Considerations for Optimizing Dosing of Immunoglobulins Based on Pharmacokinetic Evidence

por Mahmood, Iftekhar, Tegenge, Million A., Golding, Basil
Publicado 2020

Dosing Considerations for Antibodies Against COVID-19

por Tegenge, Million A., Mahmood, Iftekhar, Struble, Evi, Golding, Basil
Publicado 2020

Opportunities and challenges for applying model‐informed drug development approaches to gene therapies

por Belov, Artur, Schultz, Kimberly, Forshee, Richard, Tegenge, Million A.
Publicado 2021

Advancing the science of patient input throughout the regulatory decision‐making process

por Tegenge, Million A., Moncur, Megan M., Sokolic, Robert, Forshee, Richard A., Irony, Telba
Publicado 2017

Development of best practices in physiologically based pharmacokinetic modeling to support clinical pharmacology regulatory decision‐making—A workshop summary

por Jean, Daphney, Naik, Kunal, Milligan, Lauren, Hall, Stephen, Mei Huang, Shiew, Isoherranen, Nina, Kuemmel, Colleen, Seo, Paul, Tegenge, Million A., Wang, Yaning, Yang, Yuching, Zhang, Xinyuan, Zhao, Liang, Zhao, Ping, Benjamin, Jessica, Bergman, Kimberly, Grillo, Joseph, Madabushi, Rajanikanth, Wu, Fang, Zhu, Hao, Zineh, Issam
Publicado 2021